Fredrik Müller focuses on Immunology, Internal medicine, Tumor necrosis factor alpha, Endocrinology and Cytokine. The Immunopathology, Monocyte and Chemokine research Fredrik Müller does as part of his general Immunology study is frequently linked to other disciplines of science, such as Unstable angina, therefore creating a link between diverse domains of science. His study focuses on the intersection of Tumor necrosis factor alpha and fields such as Virus with connections in the field of Homeostasis and Intracellular.
His Endocrinology research incorporates themes from Antiretroviral treatment and IL-2 receptor. His work carried out in the field of Cytokine brings together such families of science as Immune system, Common variable immunodeficiency, Receptor, Proinflammatory cytokine and In vivo. His biological study deals with issues like Pathogenesis, which deal with fields such as CD40, Cardiovascular agent, Platelet activation and Platelet.
His primary areas of investigation include Immunology, Internal medicine, Cytokine, Endocrinology and Monocyte. His Immunology study frequently draws connections between related disciplines such as Peripheral blood mononuclear cell. His Internal medicine research integrates issues from Gastroenterology and Cardiology.
His Cytokine study combines topics in areas such as Proinflammatory cytokine and Antibody. The various areas that Fredrik Müller examines in his Endocrinology study include T cell and Antagonist. He combines subjects such as Chemokine and Macrophage with his study of Monocyte.
Fredrik Müller spends much of his time researching Internal medicine, Immunology, Pediatrics, Norwegian and Intensive care medicine. His Internal medicine research includes themes of Mucormycosis and Aspergillosis. His studies in Immunology integrate themes in fields like Staphylococcal infections and Single-nucleotide polymorphism, Genotype.
His research in Pediatrics intersects with topics in Tertiary care hospital, Defined daily dose, Antibiotic use and Meropenem. In his study, which falls under the umbrella issue of Intensive care medicine, Community-acquired pneumonia is strongly linked to Etiology. His studies deal with areas such as Interleukin 6, Cytokine, Gastroenterology, Chemotaxis and Macrophage as well as Prospective cohort study.
His main research concerns Community-acquired pneumonia, Internal medicine, Complement system, Respiratory system and Multilocus sequence typing. His Community-acquired pneumonia study combines topics from a wide range of disciplines, such as Streptococcus pneumoniae, Medical microbiology, Microbiology, Rhinovirus and Pathology. In general Internal medicine, his work in Etiology, Prospective cohort study and Cause of death is often linked to Hazard ratio linking many areas of study.
Immunology covers Fredrik Müller research in Complement system. Fredrik Müller interconnects Odds ratio and Case-control study in the investigation of issues within Respiratory system. His Multilocus sequence typing research includes elements of Genome, Whole genome sequencing, Horizontal gene transfer and Plasmid.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Enhanced Levels of Soluble and Membrane-Bound CD40 Ligand in Patients With Unstable Angina Possible Reflection of T Lymphocyte and Platelet Involvement in the Pathogenesis of Acute Coronary Syndromes
Pål Aukrust;Fredrik Müller;Thor Ueland;Trude Berget.
Circulation (1999)
Cytokine network in congestive heart failure secondary to ischemic or idiopathic dilated cardiomyopathy.
Pål Aukrust;Thor Ueland;Egil Lien;Klaus Bendtzen.
American Journal of Cardiology (1999)
Elevated Circulating Levels of C-C Chemokines in Patients With Congestive Heart Failure
Pål Aukrust;Thor Ueland;Fredrik Müller;Arne K. Andreassen.
Circulation (1998)
Release of cytokines, soluble cytokine receptors, and interleukin-1 receptor antagonist after intravenous immunoglobulin administration in vivo.
P Aukrust;SS Froland;NB Liabakk;F Muller.
Blood (1994)
Decreased bone formative and enhanced resorptive markers in human immunodeficiency virus infection: indication of normalization of the bone-remodeling process during highly active antiretroviral therapy.
Pål Aukrust;Charlotte J. Haug;Thor Ueland;Egil Lien.
The Journal of Clinical Endocrinology and Metabolism (1999)
Reduced, oxidized and protein-bound forms of homocysteine and other aminothiols in plasma comprise the redox thiol status--a possible element of the extracellular antioxidant defense system.
Per M. Ueland;M. Azam Mansoor;Anne B. Guttormsen;Fredrik Müller.
Journal of Nutrition (1996)
Enhanced T-cell expression of RANK ligand in acute coronary syndrome: possible role in plaque destabilization.
Wiggo J. Sandberg;Arne Yndestad;Erik Øie;Camilla Smith.
Arteriosclerosis, Thrombosis, and Vascular Biology (2006)
IL-10 in HIV infection: increasing serum IL-10 levels with disease progression--down-regulatory effect of potent anti-retroviral therapy.
E Stylianou;P Aukrust;D Kvale;F Müller.
Clinical and Experimental Immunology (1999)
Tumor Necrosis Factor (TNF) System Levels in Human Immunodeficiency Virus—Infected Patients during Highly Active Antiretroviral Therapy: Persistent TNF Activation Is Associated with Virologic and Immunologic Treatment Failure
Pål Aukrust;Fredrik Müller;Egil Lien;Ingvild Nordøy.
The Journal of Infectious Diseases (1999)
Enhanced activation of platelets with abnormal release of RANTES in human immunodeficiency virus type 1 infection
Pål André Holme;Fredrik Müller;Nils Olav Solum;Frank Brosstad.
The FASEB Journal (1998)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:
University of Oslo
Oslo University Hospital
Oslo University Hospital
University of Massachusetts Medical School
University of Bergen
Norwegian University of Science and Technology
Oslo University Hospital
Oslo University Hospital
Oslo University Hospital
Leibniz Institute of Photonic Technology
Nokia (United States)
University of Duisburg-Essen
University of Freiburg
Sapienza University of Rome
École Polytechnique Fédérale de Lausanne
Shimadzu Corp
SinoHyKey
Leibniz Institute of Photonic Technology
University of Wisconsin–Madison
University of Missouri
University of Massachusetts Amherst
Albert Einstein College of Medicine
California Institute of Technology
Kyoto University
Vrije Universiteit Amsterdam
University of Birmingham